Breast Tissue Expander Market Size to grow by USD 282.4 million between 2024-2028
According to a research report “ Breast Tissue Expander Market” by End-user (Hospitals, Cosmetology clinics, Cancer institutes) Product (Saline-filled breast tissue expanders, Air-filled breast tissue expanders) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 282.4 million, at a CAGR of 6.78% during the forecast period. In the global healthcare industry, the demand for breast tissue expanders is significant due to the high prevalence of breast cancer among women. Approximately 245,000 women in the US alone are diagnosed with this disease annually, with elderly females aged 50 and above being disproportionately affected. As part of the mastectomy procedure to remove cancerous cells, breast reconstruction surgeries utilizing expanders are commonly chosen. Risk factors such as aging, genetic mutations, and family history of breast cancer contribute to the rising incidence of breast cancer, thereby fueling market growth for breast tissue expanders..
Browse market data tables, figures, and in-depth TOC on “Breast Tissue Expander Market” by End-user (Hospitals, Cosmetology clinics, Cancer institutes) Product (Saline-filled breast tissue expanders, Air-filled breast tissue expanders) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample
By End-user, the Hospitals segment is projected to dominate the market size in 2024
The Breast Tissue Expander market represents a significant expansion opportunity for medical device manufacturers. This market involves the production and distribution of devices used to gradually expand the breast tissue in preparation for breast reconstruction or augmentation surgery. Market growth is driven by increasing breast reconstruction procedures and the rising demand for cosmetic surgeries. Companies must focus on innovation, quality, and regulatory compliance to capture market share and meet consumer expectations.
By Product, Saline-filled breast tissue expanders segment is expected to hold the largest market size for the year 2024
The Breast Tissue Expander market represents a significant expansion opportunity for medical device manufacturers. This market involves the production and distribution of devices used to gradually expand the breast tissue in preparation for breast reconstruction or augmentation surgery. Market growth is driven by increasing breast reconstruction procedures and the rising demand for cosmetic surgeries. Companies must focus on innovation, quality, and regulatory compliance to capture market share and meet consumer expectations.
North America is forecasted to hold the largest market size by region in 2024
The Breast Tissue Expander market represents a significant expansion opportunity for medical device manufacturers. This market involves the production and distribution of devices used to gradually expand the breast tissue in preparation for breast reconstruction or augmentation surgery. Market growth is driven by increasing breast reconstruction procedures and the rising demand for cosmetic surgeries. Companies must focus on innovation, quality, and regulatory compliance to capture market share and meet consumer expectations.
The Breast Tissue Expander Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:
.
For insights on company offerings- Request a sample report!
Research Analysis Overview
In the realm of medical technology, the Breast Tissue Expander market holds significant importance, particularly in the context of Aesthetic surgeries and Reconstructive surgeries. This market caters to various clinical needs, including Face & Neck Reconstruction, Scalp Reconstruction, and Forehead Skin Reconstruction, among others. The high costs associated with these procedures and the regulatory challenges pose significant hurdles for market growth. The Breast Tissue Expander market encompasses a range of products, including Acellular Dermal Matrix and Tissue Expanders. Notable players in this market include Allergan, which has faced recalls and product failures, leading to concerns regarding capsular contracture. Advancements in medical technology have led to innovations such as Silicone implants, Resomer bioresorbable polymer, and 3D-printed implants. These developments aim to address the needs of an aging population and improve breast prosthetics, while also facilitating procedures like Mastectomy. Reimbursements and awareness campaigns play crucial roles in expanding market reach and ensuring patient access to these essential medical devices. Furthermore, ongoing clinical trials contribute to the continuous advancement of breast tissue expanders and related cosmetic procedures, such as Liposuction and Breast cancer treatments.
Market Research Overview
In the field of breast reconstruction, tissue expanders play a crucial role in preparing the body for breast conserving surgery or implant placement. The breast tissue expander market caters to patient preferences for improved quality of life and aesthetic outcomes. Surgical oncology and cosmetology clinics, hospitals, and ambulatory surgical centers offer various reconstruction options, including round, crescent, and rectangular expanders. High costs and regulatory challenges associated with medical technology and cosmetic procedures pose challenges to the breast tissue expander market. However, advancements in surgical techniques, such as the use of acellular dermal matrix, tissue expanders, and breast implants, contribute to the growth of this segment. Breast cancer awareness and the aging population drive the demand for breast reconstruction treatments, including breast augmentation and mastectomy. Post-surgery complications, such as capsular contracture, and product failures, including recalls of silicone implants, impact patient satisfaction and market trends. Innovations in breast prosthetics, such as Resomer bioresorbable polymer and 3D-printed implants, offer potential solutions to address product shape and patient preferences. Reimbursements and clinical trials for breast reconstruction treatments further fuel market growth.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
